1. Merck Joins Pfizer to Develop Type 2 Diabetes Drug;Genetic Engineering Biotechnology News,2013
2. FDA Approves SGLT2 Inhibitor Steglatro™ (Ertugliflozin) and Fixed-Dose Combination Steglujan™ (Ertugliflozin and Sitagliptin) for Adults with Type 2 Diabetes;Pfizer,2017
3. Drugs to Watch – 2018. The Year of Blockbuster Drugs;Goel,2018
4. From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids;Moulton;Chem. Rev.,2001
5. Crystal Engineering: The Design of Organic Solids;Desiraju,1989